CAMBRIDGE, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the pricing of its public offering of 9,100,000 shares of its common stock at a price of $33.00 per share. The gross proceeds, before commissions and expenses, of the public offering will be approximately $300.3 million. All of the shares are being offered by Vertex. The Company has also granted the underwriters a 30-day option to purchase up to an additional 900,000 shares to cover over-allotments, if any.
